Rapport Therapeutics, Inc. Common Stock

Rapport Therapeutics, Inc. Common Stock

RAPP
Rapport Therapeutics, Inc. Common StockUS flagNASDAQ Global Market
42.56
USD
+2.35
- -
1.55BMarket Cap

Income Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
- -
36
83
125
+ Selling, General & Admin
- -
8
22
30
+ Research & Development
- -
28
61
95
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
- -
-36
-83
-125
- Non-Operating (Income) Loss
- -
-1
-5
-14
+ Interest Expense, Net
- -
-3
-12
-14
+ Interest Expense
- -
- -
- -
- -
- Interest Income
- -
3
12
14
+ Other Non-Op (Income) Loss
- -
1
7
- -
Pretax Income
- -
-35
-78
-111
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-35
-78
-111
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-35
-78
-111
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
- -
-35
-78
-111
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-35
-78
-111
EBIT
- -
-36
-83
-125
EBITDA
- -
-36
-82
-124
EBITDA Margin (%)
- -
- -
- -
- -
EBITA
- -
-36
-83
-125
Gross Margin (%)
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
1
1
Basic Weighted Avg Shares
- -
2
21
39
Basic EPS, GAAP
- -
-23.1
-3.78
-2.86
Basic EPS from Cont Ops
- -
-23.1
-3.78
-2.86
Diluted Weighted Avg Shares
- -
2
21
39
Diluted EPS, GAAP
- -
-23.1
-3.78
-2.86
Diluted EPS from Cont Ops
- -
-23.1
-3.78
-2.86

Balance Sheet (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
31
151
310
499
+ Cash, Cash Equivalents & STI
31
147
305
491
+ Cash & Cash Equivalents
31
70
57
53
+ ST Investments
- -
77
248
438
+ Accounts & Notes Receiv
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
- -
3
5
8
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
- -
5
5
14
+ Property, Plant & Equip, Net
- -
4
5
13
+ Property, Plant & Equip
- -
4
6
15
- Accumulated Depreciation
- -
- -
1
2
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
- -
1
- -
1
+ Total Intangible Assets
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
1
- -
1
Total Assets
32
155
315
512
+ Payables & Accruals
2
6
4
9
+ Accounts Payable
1
3
2
4
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
- -
3
2
5
+ ST Debt
- -
1
1
3
+ ST Borrowings
- -
- -
- -
- -
+ ST Finance Leases
- -
1
1
3
+ Other ST Liabilities
- -
2
4
7
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
- -
2
4
7
Total Current Liabilities
2
9
9
19
+ LT Debt
- -
1
1
9
+ LT Borrowings
- -
- -
- -
- -
+ LT Finance Leases
- -
1
1
9
+ Other LT Liabilities
40
171
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
40
171
- -
- -
Total Noncurrent Liabilities
40
172
1
9
Total Liabilities
42
181
10
28
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
1
20
430
719
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
1
20
430
719
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-11
-45
-124
-235
+ Other Equity
- -
- -
-1
1
Equity Before Minority Interest
-10
-26
305
485
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-10
-26
305
485
Total Liabilities & Equity
32
155
315
512
Shares Outstanding
35
35
37
48
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
- -
2
1
11
Net Debt
-31
-70
-57
-53
Net Debt to Equity
309.67
273.73
-18.6
-10.86
Tangible Common Equity Ratio
-31.84
-16.49
96.98
94.58
Current Ratio
18.8
17.14
35.34
26.17
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
- -
-35
-78
-111
+ Depreciation & Amortization
- -
- -
1
1
+ Non-Cash Items
- -
5
15
19
+ Stock-Based Compensation
- -
4
10
19
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
1
5
1
+ Chg in Non-Cash Work Cap
- -
3
-2
4
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-3
-2
-4
+ Inc (Dec) in Accts Payable
- -
6
- -
8
+ Inc (Dec) in Other
- -
- -
-1
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
- -
-27
-65
-87
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
-2
-2
-1
+ Acq of Fixed Prod Assets
- -
-2
-2
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
158
269
+ Increase in Capital Stock
- -
- -
158
269
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
-77
-168
-187
+ Dec in LT Investment
- -
- -
210
168
+ Inc in LT Investment
- -
-77
-378
-355
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
- -
-79
-170
-187
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
+ Other Financing Activities
- -
145
64
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
- -
145
222
271
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
- -
39
-13
-4
EBITDA
- -
-36
-82
-124
EBITDA Margin (%)
- -
- -
- -
- -
Free Cash Flow
- -
-29
-67
-88
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-29
-67
-88
Free Cash Flow per Basic Share
- -
-19.14
-3.24
-2.26
Price/Free Cash Flow
- -
- -
-5.89
-13.6
Cash Flow to Net Income
- -
0.78
0.83
0.78
Capital Expenditures
- -
-2
-2
-1